Niaz Ahmed Selected Research

Niaz Ahmed Research Topics

Disease

74	Stroke (Strokes) 12/2023 - 01/2003
49	Ischemic Stroke 01/2024 - 01/2003
11	Cerebral Hemorrhage 01/2019 - 12/2008
8	Infarction (Infarctions) 12/2023 - 01/2004
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2023 - 08/2014
4	Brain Edema (Cerebral Edema) 12/2023 - 01/2020
4	Hemorrhage 01/2022 - 06/2012
3	Atrial Fibrillation 01/2020 - 06/2014
2	Ischemia 01/2023 - 12/2015
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 12/2018 - 03/2018
2	Hypertension (High Blood Pressure) 06/2012 - 07/2009
2	Body Weight (Weight, Body) 06/2012 - 06/2011
1	Hyperlipidemias (Hyperlipidemia) 10/2023
1	Hematoma 10/2023
1	Paresis (Hemiparesis) 06/2022
1	Tuberculosis (Tuberculoses) 11/2021
1	Virus Diseases (Viral Diseases) 03/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Lacunar Stroke 12/2019
1	Hemorrhagic Stroke 10/2019
1	Hyperglycemia 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Edema (Dropsy) 01/2017
1	Temporomandibular ankylosis 03/2016
1	Aphasia (Dysphasia) 11/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2014
1	Hemianopsia (Bitemporal Hemianopsia) 10/2012
1	Clinical Deterioration 06/2012
1	Heart Failure 12/2008
1	Falciparum Malaria (Plasmodium falciparum Malaria) 06/2008
1	Jaundice (Icterus) 06/2008
1	Acute Kidney Injury (Acute Renal Failure) 06/2008
1	Hepatitis 06/2008
1	Thrombocytopenia (Thrombopenia) 06/2008

Drug/Important Bio-Agent (IBA)

52	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 12/2023 - 01/2007
22	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2007
6	Blood Glucose (Blood Sugar)IBA 01/2023 - 12/2008
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 06/2012
3	Tenecteplase FDA Link 01/2022 - 01/2021
2	2,6-dinitrotoluene (DNT)IBA 05/2015 - 06/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2012 - 12/2008
1	Indicators and Reagents (Reagents)IBA 12/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	CholesterolIBA 01/2023
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 11/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 11/2021
1	VaccinesIBA 03/2021
1	Antiviral Agents (Antivirals)IBA 03/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	ZincIBA 01/2021
1	VitaminsIBA 01/2021
1	Dabigatran FDA Link 01/2020
1	1- (diethylaminopropyl)- 4- phenylpiperazineIBA 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	AnticoagulantsIBA 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 08/2013
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2012
1	Clopidogrel (Plavix)FDA Link 06/2012
1	Antihypertensive Agents (Antihypertensives)IBA 07/2009
1	Dacarbazine (DIC)FDA LinkGeneric 06/2008
1	Neuroprotective AgentsIBA 01/2004
1	Free RadicalsIBA 01/2004
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2004
1	CalciumIBA 01/2004
1	Biomarkers (Surrogate Marker)IBA 01/2004
1	Nimodipine (Modus)FDA LinkGeneric 01/2003

Therapy/Procedure

21	Thrombectomy 01/2024 - 09/2017
13	Therapeutics 01/2023 - 07/2009
4	Thrombolytic Therapy 01/2017 - 01/2007
2	Treatment Delay 09/2016 - 12/2015
2	Contraindications 12/2015 - 10/2015
1	Off-Label Use 01/2022
1	Stents 01/2021
1	Punctures 01/2020
1	Arthroplasty 03/2016
1	Aftercare (After-Treatment) 06/2014